Clinical Education InitiativeMenu
Search
Home > Courses > Syphilis Diagnostics, Still Clear as Mud; Syphilis Therapeutics, Not So Much. And Maximizing Syphilis Treatment: Is That History of Penicillin Allergy Real?

Syphilis Diagnostics, Still Clear as Mud; Syphilis Therapeutics, Not So Much. And Maximizing Syphilis Treatment: Is That History of Penicillin Allergy Real?

Syphilis Diagnostics, Still Clear as Mud; Syphilis Therapeutics, Not So Much. And Maximizing
Play
Sorry, this learning module is not available for mobile devices.
Original Presentation: 3/10/2015
Web Posting: 6/19/2015
CE Expiration: 03/10/2018
Presenters
  • Sujan Patel, MD
    Assistant Professor of Allergy and Immunology
    Mount Sinai in New York, NY
  • Michael H. Augenbraun, MD, FACP
    Professor of Medicine and Professor of Preventive Medicine and Community Health
    SUNY Downstate College of Medicine
Learning Objectives
At the completion of this educational session, participants will:
  1. Recognize which syphilis serologic testing combinations signify infection, which warrant therapy, and which indicate successful therapy.
  2. Know current CDC recommendations for syphilis treatment.
  3. Be aware of the protocol for penicillin desensitization.
  4. Understand the data regarding penicillin allergy in the US, recommendations for evaluation of reported penicillin allergy, and which reported adverse reactions preclude penicillin testing or desensitization.
Presenter Bios
Sujan Patel, MD
Sujan Patel is Assistant Professor of Allergy and Immunology, in the Department of Otolaryngology, at The New York Eye and Ear Infirmary of Mount Sinai in New York, NY.
Michael Augenbraun, MD, FACP
Mike Augenbraun, MD was appointed as chief of the Division of Infectious Diseases (ID) at SUNY Downstate in 2011. He has been at Downstate for over 25 years, since beginning his clinical fellowship in ID in 1988. Dr. Augenbraun did his undergraduate and medical studies at the University of Rochester School of Medicine and Dentistry. After a residency at North Shore, he undertook a research fellowship in ID at SUNY Downstate and then joined the faculty, in which he is now professor of Medicine and Public Health. Dr. Augenbraun has a longstanding clinical and research interest in STDs and in the response of HIV infected individuals to common pathogens and whether the natural history of such infections and their response to therapy is altered.
Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit™ on March 10, 2015 and will terminate March, 2018.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length. 

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity. 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose. 
  • Dr. Augenbraun (Presenter) had no relevant financial relationships to disclose. Dr. Augenbraun supported his presentation and clinical recommendations with the best available evidence from the medical literature, and submitted his slides in advance for adequate peer review.
  • Dr. Patel (Presenter) had no relevant financial relationships to disclose. Dr. Patel supported his presentation and clinical recommendations with the best available evidence from the medical literature, and submitted his slides in advance for adequate peer review.

Financial Support

This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co, and ViiV Healthcare.

PRN Learning Modules